The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Control of mitochondrial apoptosis by the Bcl-2 family
Open accessAbstract
Programmed cell death, or apoptosis, is important for the development and homeostasis of tissues. Too little cell death can result in autoimmune diseases or cancer, whereas excessive cell death can lead to debilitating degenerative diseases of the heart or nervous system. The realization that apoptosis was genetically controlled first arose when it was observed that certain mutants of the model organism Caenorhabditis elegans caused failure of apoptosis in cells that normally undergo this process during development (Hengartner et al., 1992). Subsequently, it was found that proteins that are encoded by the mutant genes discovered in C. elegans shared homology with mammalian proteins, including B-cell CLL/lymphoma 2 (Bcl-2) (Hengartner and Horvitz, 1994). Further study in mammals revealed that there is an intrinsic apoptotic pathway that involves the mitochondria and an extrinsic apoptotic pathway that involves death receptors. The mitochondrial pathway of apoptosis in mammals, on which this poster article is focused, is regulated by members of the Bcl-2 family of proteins.Proteins of the Bcl-2 family have either pro- or anti-apoptotic activities and regulate the mitochondrial pathway of apoptosis by controlling the permeabilization of the outer mitochondrial membrane. In response to many types of stress or damage, certain members of the Bcl-2 family, known as BH3-only proteins (see below), are activated. Certain BH3-only proteins cause the activation of the pro-apoptotic proteins Bcl-2-associated X protein (Bax) or Bcl-2 antagonist/killer-1 (Bak) at the mitochondrion. Activated Bax and Bak homo-oligomerize and participate in the formation of pores in the outer mitochondrial membrane through which pro-apoptotic molecules escape, including second mitochondria-derived activator of caspase (Smac) (also known as Diablo) and cytochrome c. Release of cytochrome c leads to the activation of caspases, which are proteases that cleave key cellular proteins. This leads to many of the morphological characteristics of apoptosis, including condensed nuclei, DNA laddering and exposure of phosphatidylserine to the outer leaflet of the plasma membrane.Expression of Bcl-2 or other related anti-apoptotic proteins, including myeloid cell leukemia-1 (Mcl-1), Bcl-2-like 1 (Bcl-XL), Bcl-2-like 2 (Bcl-w) and Bcl-2-related protein A1 (Bfl-1), block cell death in response to many varieties of insult by preventing the activation and homo-oligomerization of both Bax and Bak. Anti-apoptotic proteins perform their anti-death function by sequestering BH3-only proteins or activated, monomeric Bax and Bak. Cells that survive continuous, permanent death signaling owing to the presence of Bcl-2 are dependent on Bcl-2 for their survival. It is known that certain cancer cells depend upon Bcl-2 and other anti-apoptotic proteins for survival. We have found that dependence on anti-apoptotic proteins can be identified in cancer cells using a strategy that we call BH3 profiling (see below and Box 1). In cancer cells that are dependent on Bcl-2, the Bcl-2 protein binds pro-apoptotic BH3-only proteins such as Bcl-2-interacting mediator of cell death (Bim). We describe such cells as being `primed for death'. Molecular therapies that are targeted to anti-apoptotic proteins such as Bcl-2 can induce apoptosis in primed cancer cells; one such Bcl-2 antagonist, Abbott (ABT)-737, has shown impressive success in killing leukemia and lymphoma cells (Table 1).In this brief Cell Science at a Glance poster article, we discuss how proteins of the Bcl-2 family control the crucial event in the commitment to apoptosis – the permeabilization of the mitochondrial outer membrane. In addition, we discuss recently developed methods for probing how cancer cells manipulate members of the Bcl-2 family to block apoptosis. Understanding these principles is key to understanding how certain insults and derangements commit selected cells to death, but spare others.The Bcl-2 family can be divided into pro-apoptotic and anti-apoptotic proteins. These proteins contain one or more Bcl-2 homology (BH) domains, which share sequence homology and are important for heterodimeric interactions among members of the Bcl-2 family (Chittenden et al., 1995; Danial and Korsmeyer, 2004). Most anti-apoptotic proteins contain BH domains 1-4. Pro-apoptotic proteins can be divided into two groups according to function and the number of BH domains possessed. Bax and Bak are pro-apoptotic proteins that contain BH domains 1-3 and are known as multidomain pro-apoptotic or effector proteins. The remaining pro-apoptotic proteins contain only the third BH domain and are known as BH3-only proteins. BH3-only proteins act as upstream sentinels of cellular damage and derangement. They can be activated by many noxious stimuli – including DNA damage, growth-factor withdrawal and oncogene activation – via mechanisms that include transcriptional upregulation, subcellular localization and/or post-translational modific
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programed cell death
Oltval, Z. N., Milliman, C. L., & Korsmeyer, S. J. (1993) · Cell · doi:10.1016/0092-8674(93)90509-o · Cited by 6,003
The Release of Cytochrome c from Mitochondria: A Primary Site for Bcl-2 Regulation of Apoptosis
Kluck, R. M., Bossy-Wetzel, E., Green, D. R., & Newmeyer, D. D. (1997) · Science · doi:10.1126/science.275.5303.1132 · Cited by 4,714
Danial, N. N., & Korsmeyer, S. J. (2004) · Cell · doi:10.1016/s0092-8674(04)00046-7 · Cited by 4,651
Cleavage of BID by Caspase 8 Mediates the Mitochondrial Damage in the Fas Pathway of Apoptosis
Li, H., Zhu, H., Xu, C.-J., & Yuan, J. (1998) · Cell · doi:10.1016/s0092-8674(00)81590-1 · Cited by 4,445
Proapoptotic BAX and BAK: A Requisite Gateway to Mitochondrial Dysfunction and Death
Wei, M. C., Zong, W.-X., Cheng, E. H.-Y., Lindsten, T., Panoutsakopoulou, V., Ross, A. J., Roth, K. A., MacGregor, G. R., Thompson, C. B., & Korsmeyer, S. J. (2001) · Science · doi:10.1126/science.1059108 · Cited by 3,988
miR-15 and miR-16 induce apoptosis by targeting BCL2
Cimmino, A., Calin, G. A., Fabbri, M., Iorio, M. V., Ferracin, M., Shimizu, M., Wojcik, S. E., Aqeilan, R. I., Zupo, S., Dono, M., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506654102 · Cited by 3,517
An inhibitor of Bcl-2 family proteins induces regression of solid tumours
Oltersdorf, T., Elmore, S. W., Shoemaker, A. R., Armstrong, R. C., Augeri, D. J., Belli, B. A., Bruncko, M., Deckwerth, T. L., Dinges, J., Hajduk, P. J., et al. (2005) · Nature · doi:10.1038/nature03579 · Cited by 3,416
Self-citationBcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells
Vaux, D. L., Cory, S., & Adams, J. M. (1988) · Nature · doi:10.1038/335440a0 · Cited by 3,219
Zha, J., Harada, H., Yang, E., Jockel, J., & Korsmeyer, S. J. (1996) · Cell · doi:10.1016/s0092-8674(00)81382-3 · Cited by 2,595
(2001) · PubMed · Cited by 2,381
Cited by
Pistritto, G., Trisciuoglio, D., Ceci, C., Garufi, A., & D'Orazi, G. (2016) · Aging · doi:10.18632/aging.100934 · Cited by 1,658
Role of Bcl-2 family proteins and caspases in the regulation of apoptosis
Ola, M. S., Nawaz, M., & Ahsan, H. (2011) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-010-0709-x · Cited by 920
The mystery of BCL2 family: Bcl-2 proteins and apoptosis: an update
Siddiqui, W. A., Ahad, A., & Ahsan, H. (2015) · Archives of Toxicology · doi:10.1007/s00204-014-1448-7 · Cited by 696
Anti-apoptosis and cell survival: A review
Portt, L., Norman, G., Clapp, C., Greenwood, M., & Greenwood, M. T. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2010.10.010 · Cited by 636
The Unfolded Protein Response: Integrating Stress Signals Through the Stress Sensor IRE1α
Hetz, C., Martinon, F., Rodriguez, D., & Glimcher, L. H. (2011) · Physiological Reviews · doi:10.1152/physrev.00001.2011 · Cited by 569
Pathological effects of ionizing radiation: endothelial activation and dysfunction
Baselet, B., Sonveaux, P., Baatout, S., & Aerts, A. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-018-2956-z · Cited by 552
Mitochondrial dysfunction and oxidative stress in aging and cancer
Kudryavtseva, A. V., Krasnov, G. S., Dmitriev, A. A., Alekseev, B. Y., Kardymon, O. L., Sadritdinova, A. F., Fedorova, M. S., Pokrovsky, A. V., Melnikova, N. V., Kaprin, A. D., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.9821 · Cited by 543
Evaluation of the use of therapeutic peptides for cancer treatment
Marqus, S., Pirogova, E., & Piva, T. J. (2017) · Journal of Biomedical Science · doi:10.1186/s12929-017-0328-x · Cited by 512
BCL-2 protein family: attractive targets for cancer therapy
Kaloni, D., Diepstraten, S. T., Strasser, A., & Kelly, G. L. (2023) · Apoptosis · doi:10.1007/s10495-022-01780-7 · Cited by 500
Endoplasmic-Reticulum Calcium Depletion and Disease
Mekahli, D., Bultynck, G., Parys, J. B., De Smedt, H., & Missiaen, L. (2011) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a004317 · Cited by 478
Necrotic, apoptotic and autophagic cell fates triggered by nanoparticles
Mohammadinejad, R., Moosavi, M. A., Tavakol, S., Vardar, D. Ö., Hosseini, A., Rahmati, M., Dini, L., Hussain, S., Mandegary, A., & Klionsky, D. J. (2019) · Autophagy · doi:10.1080/15548627.2018.1509171 · Cited by 453
Regulation of the Apaf-1–caspase-9 apoptosome
Bratton, S. B., & Salvesen, G. S. (2010) · Journal of Cell Science · doi:10.1242/jcs.073643 · Cited by 433
Daulatzai, M. A. (2017) · Journal of Neuroscience Research · doi:10.1002/jnr.23777 · Cited by 429
Vidya Priyadarsini, R., Senthil Murugan, R., Maitreyi, S., Ramalingam, K., Karunagaran, D., & Nagini, S. (2010) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2010.09.020 · Cited by 399
Vo, T.-T., Ryan, J., Carrasco, R., Neuberg, D., Rossi, D. J., Stone, R. M., DeAngelo, D. J., Frattini, M. G., & Letai, A. (2012) · Cell · doi:10.1016/j.cell.2012.08.038 · Cited by 348
Self-citationMitochondria—Judges and Executioners of Cell Death Sentences
Bhola, P. D., & Letai, A. (2016) · Molecular Cell · doi:10.1016/j.molcel.2016.02.019 · Cited by 326
Self-citationWhy do BCL-2 inhibitors work and where should we use them in the clinic?
Montero, J., & Letai, A. (2018) · Cell Death & Differentiation · doi:10.1038/cdd.2017.183 · Cited by 327
Self-citationApoptotic cell signaling in cancer progression and therapy
Plati, J., Bucur, O., & Khosravi-Far, R. (2011) · Integrative Biology · doi:10.1039/c0ib00144a · Cited by 319
Ouali, A., Gagaoua, M., Boudida, Y., Becila, S., Boudjellal, A., Herrera-Mendez, C. H., & Sentandreu, M. A. (2013) · Meat Science · doi:10.1016/j.meatsci.2013.05.010 · Cited by 290
Chemotherapy-Induced Cardiotoxicity: Overview of the Roles of Oxidative Stress
Angsutararux, P., Luanpitpong, S., & Issaragrisil, S. (2015) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2015/795602 · Cited by 288
Apoptosome Structure, Assembly, and Procaspase Activation
Yuan, S., & Akey, C. W. (2013) · Structure · doi:10.1016/j.str.2013.02.024 · Cited by 281
Pahuja, R., Seth, K., Shukla, A., Shukla, R. K., Bhatnagar, P., Chauhan, L. K. S., Saxena, P. N., Arun, J., Chaudhari, B. P., Patel, D. K., et al. (2015) · ACS Nano · doi:10.1021/nn506408v · Cited by 260
Yan, F., Alinari, L., Lustberg, M. E., Katherine Martin, L., Cordero-Nieves, H. M., Banasavadi-Siddegowda, Y., Virk, S., Barnholtz-Sloan, J., Bell, E. H., Wojton, J., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-0884 · Cited by 180
Abdelkader, N. F., Safar, M. M., & Salem, H. A. (2016) · Molecular Neurobiology · doi:10.1007/s12035-014-9043-8 · Cited by 127
Proteolysis targeting chimeras (PROTACs) are emerging therapeutics for hematologic malignancies
He, Y., Khan, S., Huo, Z., Lv, D., Zhang, X., Liu, X., Yuan, Y., Hromas, R., Xu, M., Zheng, G., et al. (2020) · Journal of Hematology & Oncology · doi:10.1186/s13045-020-00924-z · Cited by 126
Dasari, V. R., Velpula, K. K., Kaur, K., Fassett, D., Klopfenstein, J. D., Dinh, D. H., Gujrati, M., & Rao, J. S. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011813 · Cited by 87
RetractedEmerging pathways of non-genomic glucocorticoid (GC) signalling in T cells
Boldizsar, F., Talaber, G., Szabo, M., Bartis, D., Palinkas, L., Nemeth, P., & Berki, T. (2010) · Immunobiology · doi:10.1016/j.imbio.2009.10.003 · Cited by 76
Fagman, H., Amendola, E., Parrillo, L., Zoppoli, P., Marotta, P., Scarfò, M., De Luca, P., de Carvalho, D. P., Ceccarelli, M., De Felice, M., et al. (2011) · Developmental Biology · doi:10.1016/j.ydbio.2011.08.015 · Cited by 67
Lewis, A., Hayashi, T., Su, T.-P., & Betenbaugh, M. J. (2014) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-013-9527-7 · Cited by 66
Interplay between protein acetylation and ubiquitination controls MCL1 protein stability
Shimizu, K., Gi, M., Suzuki, S., North, B. J., Watahiki, A., Fukumoto, S., Asara, J. M., Tokunaga, F., Wei, W., & Inuzuka, H. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109988 · Cited by 62
Gutierrez-Martinez, P., Hogdal, L., Nagai, M., Kruta, M., Singh, R., Sarosiek, K., Nussenzweig, A., Beerman, I., Letai, A., & Rossi, D. J. (2018) · Nature Cell Biology · doi:10.1038/s41556-018-0054-y · Cited by 60
Self-citationAmyotrophic lateral sclerosis pathogenesis: a journey through the secretory pathway
Nassif, M., Matus, S., Castillo, K., & Hetz, C. (2010) · Antioxidants & Redox Signaling · doi:10.1089/ars.2009.2991 · Cited by 60
Li, X., Xu, Z., Bai, J., Yang, S., Zhao, S., Zhang, Y., Chen, X., & Wang, Y. (2016) · Stem Cells International · doi:10.1155/2016/7495135 · Cited by 58
Hypoxia Promotes Acquisition of Aggressive Phenotypes in Human Malignant Mesothelioma
Kim, M.-C., Hwang, S.-H., Kim, N.-Y., Lee, H.-S., Ji, S., Yang, Y., & Kim, Y. (2018) · BMC Cancer · doi:10.1186/s12885-018-4720-z · Cited by 49
Gamal-Eldeen, A. M., Hamdy, N. A., Abdel-Aziz, H. A., El-Hussieny, E. A., & Fakhr, I. M. I. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.03.021 · Cited by 48
H. Swerdlow, R. (2011) · Current Pharmaceutical Design · doi:10.2174/138161211798072535 · Cited by 35
Timme, C. R., Gruidl, M., & Yeatman, T. J. (2013) · Apoptosis · doi:10.1007/s10495-013-0883-x · Cited by 34
Matarrese, P., Tieri, P., Anticoli, S., Ascione, B., Conte, M., Franceschi, C., Malorni, W., Salvioli, S., & Ruggieri, A. (2019) · Cell Death & Disease · doi:10.1038/s41419-019-1888-3 · Cited by 27
Pandey, S., Patil, S., Ballav, N., & Basu, S. (2020) · Journal of Materials Chemistry B · doi:10.1039/d0tb00408a · Cited by 26
Metadata
- Authors
- Brunelle, J. K., & Letai, A.
- Venue
- Journal of Cell Science
- Publisher
- The Company of Biologists
- Published
- 2009-02-15
- Volume
- 122
- Issue
- 4
- Pages
- 437-441
- ISSN
- 0021-9533 (ISSN-L)
- 1477-9137
- OpenAlex
- W2162574319
- Cited by
- 929
- References
- 46
- FWCI
- 21.12
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.